Calcutta School of Tropical Medicine is a medical institute from Kolkata, India dedicated in the field of tropical disease. It was established in 1914 by Leonard Rogers of the Indian Medical Service, professor of pathology at the Calcutta Medical College. It was, till 2003, affiliated with the University of Calcutta.

During the past decade, Calcutta School of Tropical Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Calcutta School of Tropical Medicine" are "Atopic Dermatitis" (1 trials) and "Pneumococcal Disease" (1 trials). Many other conditions were trialed in "Calcutta School of Tropical Medicine" in a lesser frequency.

Most popular intervention types in "Calcutta School of Tropical Medicine" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Calcutta School of Tropical Medicine" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Calcutta School of Tropical Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Calcutta School of Tropical Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Calcutta School of Tropical Medicine, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".